Stock AUXILIUM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Auxilium Pharmaceuticals, Inc.

Equities

US05334D1072

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Auxilium Pharmaceuticals, Inc.
2015 Endo : Exclusive: Drugmaker Endo vying for Salix takeover RE
2014 Auxilium Pharmaceuticals : Pharma accepts Endo's buyout offer, drops QLT deal RE

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Auxilium Pharmaceuticals : Announces Results from Special Meeting of Stockholders
PR
Auxilium Pharmaceuticals : Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease
PR
Auxilium Pharmaceuticals : Announces Date for Special Meeting of Stockholders
PR
Auxilium Pharmaceuticals : Presents STENDRA Data At SMSNA Scientific Meeting
PR
Auxilium Pharmaceuticals : Presents XIAFLEX For Peyronie's Disease Data At SMSNA Scientific Meeting
PR
Auxilium Pharmaceuticals : Endo Announces Early Termination of HSR Act Waiting Period in Connection with its Proposed Acquisition of Auxilium Pharmaceuticals
PR
Auxilium Pharmaceuticals : Endo Announces Early Termination of HSR Act Waiting Period in Connection with its Proposed Acquisition of Auxilium Pharmaceuticals
PR
Auxilium Pharmaceuticals : to Present XIAFLEX and STENDRA Data at SMSNA Scientific Meeting
PR
Auxilium Pharmaceuticals : Announces XIAFLEX Now Approved For The Concurrent Treatment Of Up To Two Affected Joints In The Same Hand In Dupuytren's Contracture Patients
PR
Auxilium Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Auxilium Pharmaceuticals Inc.
PR
AUXILIUM PHARMACEUTICALS : INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Auxilium Pharmaceuticals, Inc.
PR
Auxilium Pharmaceuticals : Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion
PR
Auxilium Pharmaceuticals : Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion
PR
Auxilium Pharmaceuticals : Endo International Comments On Auxilium Pharmaceutical's Rejection Of Its Acquisition Proposal
PR
Auxilium Pharmaceuticals : Licensing Agreements, Results of Clinical Trials, and Acquisitions - Research Reports on Gilead, AbbVie, Pfizer, Auxilium and Endo
PR
Auxilium Pharmaceuticals : Provides Transaction Update
PR
Auxilium Pharmaceuticals : Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting
PU
Auxilium Pharmaceuticals : Responds To Unsolicited Proposal From Endo International
PR
Auxilium Pharmaceuticals : Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock
PR
Auxilium Pharmaceuticals : Announces Corporate Restructuring Designed To Streamline Operations, Maximize Cash Flow And Drive Sustainable Earnings Growth
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Auxilium Pharmaceuticals, Inc.
  5. Press Releases